NPCE Working Capital Per Revenue	(Mar 31 2025) I. Quarter	(Dec 31 2024) IV. Quarter	(Sep 30 2024) III. Quarter	(Jun 30 2024) II. Quarter	(Mar 31 2024) I. Quarter
Y / Y Working Capital Change	16.34 %	-9 %	-11.38 %	-17.26 %	-19.29 %
Y / Y Revenue Change	28.82 %	36.68 %	27.85 %	32.21 %	35.61 %
Working Capital Per Revenue	0.85	0.86	0.95	1.05	1.18
Working Capital Per Revenue Ranking	# 1847	# 2600	# 2589	# 2648	# 2736
Seq. Working Capital Change	25.06 %	-2.4 %	0.25 %	-4.92 %	-2.18 %
Seq. Revenue Change	0.69 %	8.66 %	6.72 %	10.33 %	6.84 %

New: More NPCE's historic Working Capital Per Revenue Ratios >>

See NPCE Capital expenditures by quarter >> Back to NPCE Financial Strength Comparisons >> See NPCE Balance Sheets

Comment on NPCE's Working Capital Per Revenue in the first quarter 2025

Neuropace Inc 's Working Capital Per Revenue in the Q1 2025 sequentially fell to 0.85 a new company low.

Within Healthcare sector 32 other companies have achieved lower Working Capital Per Revenue during the Q1 2025. While Neuropace Inc Working Capital Per Revenue overall ranking has impoved so far in the Q1 2025 to 1847, from total ranking in the fourth quarter 2024 at 2600.

Working Capital Per Revenue Ranking
Within:	No.
Industry	# 4
Sector	# 33
S&P 500	# 1847

Working Capital Per Revenue Statistics
High	Average	Low
2.78	1.7	0.85
(Mar 31 2022)		(Mar 31 2025)

Financial Statements
Neuropace Inc 's Working Capital	$ 83 Millions	Visit NPCE's Balance sheet
Neuropace Inc 's Revenues	$ 22 Millions	Visit NPCE's Income Statement
Where are NPCE's Sales coming from?		Visit NPCE's Sales by Geography

Companies with similar Average Working Capital Per Revenue for 12 months ending Mar 31 2025, within Healthcare Sector	Working Capital Per Revenue
Verrica Pharmaceuticals Inc	2.32
Keros Therapeutics Inc	2.32
Entrada Therapeutics Inc	2.30
Rapid Micro Biosystems Inc	2.29
Immunocore Holdings Plc	2.27
Gossamer Bio Inc	2.23
Ginkgo Bioworks Holdings Inc	2.22
Xenetic Biosciences Inc	2.22
Humacyte Inc	2.10
Outset Medical Inc	2.06
Amarin Corp Plcuk	2.04
Cvrx inc	2.04
Moderna Inc	2.03
Butterfly Network Inc	2.00
Oncocyte Corporation	1.99
Arvinas Inc	1.98
Maravai Lifesciences Holdings Inc	1.98
Rhythm Pharmaceuticals inc	1.94
Krystal Biotech Inc	1.92
Orasure Technologies Inc	1.92
Scpharmaceuticals Inc	1.92
Assembly Biosciences Inc	1.90
Tenon Medical Inc	1.89
Omniab Inc	1.87
Invivyd Inc	1.87
Rxsight Inc	1.79
Pacific Health Care Organization Inc	1.77
Iovance Biotherapeutics inc	1.76
Arcturus Therapeutics Holdings Inc	1.72
Meiragtx Holdings Plc	1.69

Date modified: 2025-05-15T07:12:30+00:00

Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.
Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com